Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 3/20 | 0.32 |
| ▸ | CES1 | P23141 | 3/20 | 0.32 |
| ▸ | CCR5 | P51681 | 3/20 | 0.32 |
| ▸ | EEF2K | O00418 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | APAF1 | O14727 | 1/20 | 0.32 |
| ▸ | RGS12 | O14924 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 2/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | THRA | P10827 | 3/20 | 0.31 |
| ▸ | THRB | P10828 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21049621 | 1.00 | GNAI3 (0.33) | GNAI3GNAI1CES2CES1CCR5 | |
| SCHEMBL21049595 | 0.98 | L3MBTL1 (0.31) | GNAI3GNAI1CES2CES1CCR5 | |
| SCHEMBL21049599 | 0.87 | — | — | |
| SCHEMBL22188978 | 0.85 | EEF2K (0.41) | CES2CES1CCR5EEF2K | |
| SCHEMBL22189129 | 0.79 | EEF2K (0.35) | EEF2KMEN1KMT2A | |
| SCHEMBL22189101 | 0.76 | CA2 (0.41) | MEN1MAPK1KMT2A | |
| SCHEMBL21049651 | 0.70 | EEF2K (0.37) | CES2CES1CCR5EEF2K | |
| SCHEMBL22188985 | 0.70 | EEF2K (0.37) | CES2CES1CCR5EEF2K | |
| SCHEMBL21049532 | 0.70 | EEF2K (0.37) | CES2CES1CCR5EEF2K | |
| Trifluoroacetic Acid SCHEMBL7967266 | 0.70 | CCR5 (0.43) | CES2CES1CCR5EEF2KMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3604287-B1 | PRODUCTION METHOD FOR AMIDATE COMPOUND | KOEI CHEMICAL CO (JP) | 2022-08-03 | — | — | EP | disclosed |
| EP-3495353-B1 | AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN | KOEI CHEMICAL CO (JP) | 2021-11-17 | — | — | EP | disclosed |
| US-10913724-B2 | Production method for amidate compound | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2021-02-09 | — | — | US | disclosed |
| EP-3604287-A1 | PRODUCTION METHOD FOR AMIDATE COMPOUND | Koei Chemical Company, Limited (JP) | 2020-02-05 | — | — | EP | disclosed |
| EP-3495353-A1 | AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN | Koei Chemical Company, Limited (JP) | 2019-06-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10913724-B2 | Production method for amidate compound | NAAA, PAM, CCKBR | GNAI3 2442/4885GNAI1 2902/4885CES2 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.